Andrey Soares

Radiotherapy plus pembrolizumab for advanced urothelial carcinoma: results from the ARON-2 real-world study

S. Salah, R. Kanesvaran, P. Giannatempo, 2024, Scientific reports.

Sex and survival outcomes in patients with renal cell carcinoma receiving first-line immune-based combinations

A. Poprach, T. Buchler, S. Buti, 2024, Cancer immunology, immunotherapy : CII.

Pembrolizumab in Patients with Advanced Urothelial Carcinoma with ECOG Performance Status 2: A Real-World Study from the ARON-2 Project.

A. Poprach, S. Buti, R. Kanesvaran, 2024, Targeted oncology.